Analyst Research

Report Title Price
Provider: Wright Reports
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Urologix Inc Reaffirms FY 2013 Revenue Guidance

Tuesday, 5 Feb 2013 04:00pm EST 

Urologix Inc reaffirmed fiscal 2013 revenue guidance range of approximately $16.0-$17.0 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $16.0 million for fiscal 2013. 

Company Quote

-0.01 -13.79%
10:44am EDT